A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach

AUSTIN, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) — BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.9 million […]